Example: quiz answers

Impact of the DSM-IV to DSM-5 Changes on the National …

Impact OF THE DSM-IV TO DSM-5 Changes ON THE National SURVEY ON DRUG USE AND HEALTH Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality Rockville, Maryland 20857 June 2016 DISCLAIMER SAMHSA provides links to other Internet sites as a service to its users and is not responsible for the availability or content of these external sites. SAMHSA, its employees, and contractors do not endorse, warrant, or guarantee the products, services, or information described or offered at these other Internet sites. Any reference to a commercial product, process, or service is not an endorsement or recommendation by SAMHSA, its employees, or contractors. For documents available from this server, the Government does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed.

3.3.7 Obsessive-Compulsive Disorder (MHSS) 98 ... 3.4.6 Obsessive-Compulsive and Related Disorders 133 ... 3.4.12 Substance-Related and Addictive Disorders 157 3.4.13 Personality Disorders 159 3.4.14 Disorders Due to a Medical Condition, Substance Use, or Medications 159 3.4.15 Other Specified Disorders 160

Tags:

  Disorders, Personality, Obsessive, Compulsive, Compulsive disorder

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Impact of the DSM-IV to DSM-5 Changes on the National …

1 Impact OF THE DSM-IV TO DSM-5 Changes ON THE National SURVEY ON DRUG USE AND HEALTH Substance Abuse and Mental Health Services Administration Center for Behavioral Health Statistics and Quality Rockville, Maryland 20857 June 2016 DISCLAIMER SAMHSA provides links to other Internet sites as a service to its users and is not responsible for the availability or content of these external sites. SAMHSA, its employees, and contractors do not endorse, warrant, or guarantee the products, services, or information described or offered at these other Internet sites. Any reference to a commercial product, process, or service is not an endorsement or recommendation by SAMHSA, its employees, or contractors. For documents available from this server, the Government does not warrant or assume any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed.

2 This page intentionally left blank Impact OF THE DSM-IV TO DSM-5 Changes ON THE National SURVEY ON DRUG USE AND HEALTH Contract No. HHSS283201000003C RTI Project No. RTI Authors: Cristie Glasheen Kathryn Batts Rhonda Karg RTI Project Director: David Hunter SAMHSA Authors: Jonaki Bose Sarra Hedden Kathryn Piscopo SAMHSA Project Officer: Peter TiceFor questions about this report, please e-mail Prepared for Substance Abuse and Mental Health Services Administration, Rockville, Maryland Prepared by RTI International, Research Triangle Park, North Carolina June 2016 Recommended Citation: Center for Behavioral Health Statistics and Quality. (2016). Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration, Rockville, MD. ii Acknowledgments This report would not be possible without the guidance and input of staff from the Center for Behavioral Health Statistics and Quality.

3 In particular, at the Substance Abuse and Mental Health Services Administration: Janet Kuramoto, Dicy Painter, and Peggy Barker. At RTI International (a trade name of Research Triangle Institute), Mark Edlund, Justin Landwehr, and Jennifer Schoden. iii ..Table of Contents Chapter Page Executive Summary 1 Use disorders Overview 5 Categorization Changes 5 Types of Substances 9 Criteria for Substance Use disorders 9 Substance Abuse and Substance Dependence 10 Withdrawal Criteria 11 Severity Criteria 15 Specific SUDs 15 Alcohol Use Disorder 15 Caffeine Use Disorder 22 Cannabis Use Disorder 22 Phencyclidine Use Disorder and Other Hallucinogen Use Disorder 24 Inhalant Use Disorder 29 Opioid Use Disorder 33 Sedative, Hypnotic, or Anxiolytic Use Disorder 44 Stimulant Use Disorder 50 Tobacco Use Disorder 61 Other Considerations 61 Substance Use disorders in NSDUH 62 Illness Mental Illness in NSDUH and MHSS.

4 Overview 65 Overarching Structural Changes in the DSM 67 Elimination of the Multi-Axial System 67 Removal of the GAF score 68 Disorder Reclassification 71 Changes to NSDUH/MHSS Included Diagnoses 77 Major Depressive Episode/Disorder (NSDUH and MHSS) 77 Dysthymic Disorder (MHSS) 80 Manic Episode and Bipolar I Disorder (MHSS) 82 Panic Disorder and Agoraphobia (MHSS) 91 Specific Phobia (MHSS) 95 Social Phobia (MHSS) 97 obsessive - compulsive Disorder (MHSS) 98 Posttraumatic Stress Disorder (MHSS) 100 .. Generalized Anxiety Disorder (MHSS) 104 Anorexia Nervosa (MHSS) 105 Bulimia Nervosa (MHSS) 107 Intermittent Explosive Disorder (MHSS) 108 iv .. Adjustment Disorder (MHSS) 110 Psychotic disorders (MHSS) 112 Additional disorders for Consideration 117 Neurodevelopmental disorders 118 Schizophrenia Spectrum and Other Psychotic disorders 122 Bipolar and Related disorders 127 Depressive disorders 129 Anxiety disorders 131 obsessive - compulsive and Related disorders 133 Trauma- and Stressor-Related disorders 138 Somatic Symptom and Related disorders 141 Feeding and Eating disorders 145 Sleep-Wake disorders 149 Disruptive, Impulse-Control, and Conduct disorders 153 Substance-Related and Addictive disorders 157 personality disorders 159 disorders Due to a Medical Condition, Substance Use, or Medications159 Other Specified disorders 160 Other disorders in the DSM 160 Any Mental Illness, Serious Mental Illness.

5 And Specific disorders in NSDUH/MHSS 166 Impact of DSM Revisions on MHSS Estimates of SMI, AMI and Specific Disorders166 Impact on Estimates of Any Mental Illness/Serious Mental Illness 166 Impact on NSDUH Major Depressive Episode Estimates 171 References 173 Appendixes A Additional Substance Use Disorder Tables: Weighted N among People Aged 12 or Older A-1 B Additional Substance Use Disorder Tables: Prevalence among Past Year Substance Using Peoplersons Aged 12 or Older B-1 v ..List of Tables Table Page Comparison of DSM-IV , DSM-5 , and NSDUH Substance Use Disorder Assessment 6 DSM-IV to DSM-5 Withdrawal Symptom Comparison 12 Alcohol Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 17 Prevalence of DSM-5 Alcohol Use Disorder Craving Criterion from Available Studies 18 Alcohol Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 20 Respondents Who Endorsed Only One Alcohol Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic.

6 Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs21 Marijuana Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 23 Prevalence of DSM-5 Cannabis Use Disorder Craving Criterion from Available Studies 24 Phencyclidine or Other Hallucinogen Use Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 26 Phencyclidine Use Disorder or Other Hallucinogen Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 27 Respondents Who Endorsed Only One Phencyclidine Use Disorder or Other Hallucinogen Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 28 Inhalant Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 30 Inhalant Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 31 vi List of Tables (continued) Table Page.

7 Respondents Who Endorsed Only One Inhalant Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs32 Heroin Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 34 Pain Reliever Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 35 Heroin/Pain Reliever Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 36 Prevalence of DSM-5 Opioid Use Disorder Craving Criterion from Available Studies 37 Heroin Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 38 Respondents Who Endorsed Only One Heroin Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs39 Pain Reliever Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic.

8 Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 40 Respondents Who Endorsed Only One Pain Reliever Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs41 Heroin/Pain Reliever Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 42 Respondents Who Endorsed Only One Heroin/Pain Reliever Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 43 Sedative Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 45 vii List of Tables (continued) Table Page.

9 Tranquilizer Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 46 Sedative/Tranquilizer Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 47 Sedative Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 48 Respondents Who Endorsed Only One Sedative Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs49 Stimulant Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 51 Cocaine Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 52 Stimulant/Cocaine Legal Criterion Endorsement among Persons Aged 12 or Older, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 53 Prevalence of DSM-5 Cocaine Use Disorder Craving Criterion from Available Studies 54 Stimulant Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic.

10 Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 55 Respondents Who Endorsed Only One Stimulant Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs56 Cocaine Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 57 Respondents Who Endorsed Only One Cocaine Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs58 viii List of Tables (continued) Table Page .. Stimulant/Cocaine Use Disorder among Persons Aged 12 or Older under DSM-IV and DSM-5 Criteria, by Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs 59 Respondents Who Endorsed Only One Stimulant/Cocaine Use Disorder Criterion among Persons Aged 12 or Older, by Criterion and Demographic Characteristic: Weighted Percentages, Annual Averages Based on 2002-2012 NSDUHs60 Interrater Reliability Exercise Performance.


Related search queries